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Background
Dengue is the most important arboviral
disease of humans and has emerged as a
global public health problem. The dengue
case burden, and the number of countries
reporting outbreaks, has increased 10-fold
in the last 30 years. The rapidly urbanising
developing and middle-income countries
of Asia and the Americas are most
affected. Disease prevention relies, mostly
unsuccessfully, on control of the principal
mosquito vector, Aedes aegypti. Whilst there
are currently no licensed vaccines for
dengue, promising candidates are pro-
gressing through clinical development
pipelines, and the prospect of a dengue
vaccine becoming available in the next 10
years is a real one [1].
The four dengue virus serotypes co-
circulate in many endemic areas, and
intriguingly, a second infection caused by
a serotype different from an individual’s
first exposure is associated with greater risk
for severe disease. Oscillations in severe
dengue incidence have been described in
Thailand over the last 30 years, with peaks
in incidence and serotype dominance
occurring on regular cycles [2]. Interest-
ingly, Viet Nam does not necessarily
follow the same cyclical pattern [3].
The Changing Dynamics of
Dengue in Thailand
Severe dengue remains primarily a
disease of children in endemic areas, but
a measurable increase in the median age
of cases has been documented in Thailand
and anecdotally observed across much of
Asia. In this issue of PLoS Medicine, Derek
Cummings and colleagues [4] have shed
light on a plausible mechanism for this
increase by examining temporal changes
in the demographics of the Thai popula-
tion since 1985 and relating these changes
to the incidence of severe disease. During
this period, the median age of cases in
Thailand rose from ,9 years of age to
,17 years of age. Even more dramatic,
between 1999 and 2005 the median age of
cases rose from ,13 years of age to ,17
years of age. Such changes in the age-
related case burden of dengue have been
attributed to reductions in the force of
infection (the rate at which susceptible
individuals become infected) due to socio-
economic developments and/or vector
control that place fewer people at risk of
exposure [5]. However, socioeconomic
developments in Thailand have also been
accompanied by changes in the population
structure, with a lower birth rate in 2000
compared to 1985 and therefore an
increase in the median age of the popu-
lation over this period. We have observed
equivalent changes to the population
structure in Viet Nam over the same time
interval. By multivariate analysis, Cum-
mings et al. demonstrated that an increase
in median age and in the proportion of
homes constructed with permanent mate-
rials were independently associated with
the reduction in the mean force of
infection in the 72 provinces of Thailand.
Increasing median age, but not other
variables, was also independently associat-
ed with an increase in the period, or time
in years, between dengue epidemic peaks.
Sensibly, Cummings et al. have recognised
that other factors such as young, non-
immune adults migrating from lower
transmission rural settings to seek employ-
ment in urban locations with higher levels
of transmission could also explain the
change in age-related dengue epidemiolo-
gy.
What Are the Implications for
Vaccines and Clinical Practice?
The estimated reduction in the force of
infection in Thailand makes only a modest
impact on the proportion of individuals
that would need to be effectively vaccinat-
ed to stop disease transmission, with
Cummings et al. estimating the critical
vaccination threshold dropping from 85%
to 80%. More importantly, the targeted
age group for vaccination should now be
reconsidered in light of a higher average
age (,16 years) of all reported dengue
cases in Thailand. Thus, vaccination of
children as they enter primary school,
rather than during infancy, might be a
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Cummings DAT, Iamsirithaworn S,
Lessler JT, McDermott A, Pra-
santhong R, et al. (2009) The impact
of the demographic transition on
dengue in Thailand. PLoS Med 6(9):
e1000139. doi:10.1371/journal.
pmed.1000139
Analyzing data from Thailand’s 72
provinces, Derek Cummings and
colleagues find that decreases in
birth and death rates can explain
the shift in age distribution of
dengue hemorrhagic fever.
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to disease prevention, particularly for
vaccines that might not elicit lifelong
immunity from the primary vaccination
course and would therefore require boost-
er doses at multi-year intervals. Indeed, if
the mean age of dengue cases were to
continue to rise, as is possible given the
long-term trend in Thailand, then dengue
would be predominantly a disease of
young adults, and this would require a
further rethinking of vaccination strate-
gies.
A change in the age-burden of dengue
also has implications for clinical practice.
The management of severe dengue in
children has been refined by clinical
experience over the last 40 years and is
focused on very careful replacement of the
lost intravascular fluid. An increase in the
number of adults in the case mix of
dengue patients presents new challenges
to clinicians as the clinical picture can
differ from children [6]. Furthermore, the
existing World Health Organization case
classification scheme is based on clinical
experience in children, and therefore
refinements might be needed to encom-
pass the spectrum of disease in adults [7].
A priority then is to understand if other
dengue-endemic countries in Southeast
Asia and Central and South America are
experiencing similar temporal associations
between demography and dengue epide-
miology, and if so, why.
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